Interstitial Cystitis by Janosko, Edward O., II
Yale University
EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library School of Medicine
3-11-1974
Interstitial Cystitis
Edward O. Janosko II
Yale University
Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
Part of the Medicine and Health Sciences Commons
This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
Recommended Citation







Permission for photocopying or microfilming of
"
^v\-Hv^\\W Gju^ ~K \\ \ :
(TITLE OF THESIS)
for the purpose of individual scholarly consultation or reference
is hereby
granted by the author. This permission is not to be interpreted
as affect
ing publication of this work or otherwise placing it in the public domain,
and the author reserves all rights of ownership guaranteed under common







Edward O. Janosko, II
BS., Fairfield University, 1970
A thesis presented to the faculty of the
Yale University School of Medicine
in partial fulfillment of the requirements
for the degree of Doctor of Medicine
Department of Surgery


















Review of the Literature
History of Terminology
Interstitial cystitis, also referred to as "Hunner's ulcer (99),
"
is an uncommon
lesion of the urinary bladder which was first described as a clinical entity in this
country by Guy Hunner in 1914 as a "rare type of bladder ulcer (75).
"
He reported
in detail eight cases which were characterized by suprapubic pain, urinary frequency,
sterile urine, and ulceration of the vertex of the bladder seen at cystoscopy.
Previous to this, however, in 1907 Nitze in Germany described an inflammation of
the bladder which extended into the submucosa. This lesion was accompanied by
suprapubic pain, and the mucosa was seen at cystoscopy to crack on distending the
bladder. He called this "cystitis parenchymatosa (130)." The same condition was
also described by Knorr in 1908 (95). The Identification of this clinical entity has
been attributed to Mercier, Tait, and Skene (113), but this is probably Incorrect.
Mercier In 1836 described perforating ulcerations in the bladder secondary to chronic
infective cystitis (123). Tait described four cases of chronic cystitis which were
relieved symptomatica I ly by the creation of a vesico-vaginal fistula to drain the
bladder (174). These cases were not characteristic of interstitial cystitis and
probably represented infective cystitis: one case of dysuria with albuminuria and
alkaline urine, and another with spontaneous perforation of a bladder neck ulcer.




The redness of acute inflammation gradually gives way to a muddy
gray color, the membrane being smeared in places with a dark
yellow mucopurulent secretion. As the disease advances, there is
excessive cell growth on the free mucous surface. Patches of
ulceration appear here and there attended with the formation of
pus and occasional hemorrhage. . .
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In advanced cases with deep ulceration, the muscular fibres,
(which resist the destructive process longest) are occasionally seen,
stretching from one side of an ulcer to the other, forming a sort of
a bridge. . . In some cases salts of the urine are deposited. When
the disease has destroyed the mucous membrane partially or wholly,
and extends to the muscular parietes, we have what is known as
Interstitial Cystitis; and if the serous coat becomes involved we also
have pericystitis.
Perforation of the peritoneum sometimes occurs, allowing
infiltration of urine. This usually develops general Peritonitis or
Septicemia (or both) and death almost inevitably follows (161).
The condition described by Mercier, Tate, and later Fenwick was similar to that
described by Skene and was not interstitial cystitis as pointed out by Hunner in his
original observations: "I am confident that I am presenting for your consideration a
group of cases of simple ulcer of the bladder differing in many respects from the
Fenwick type ulcer (75).
"
Since Hunner's original description, a number of terms have been used to
describe this condition. Cullen named it "elusive ulcer," a term later adopted by
Hunner (72), because of the difficulty in visualizing the lesion (27). Geraghty
suggested the term "paracystitis" since the inflammation frequently involved the
paravesical tissues (58). He also called it "localized cystitis" since only a portion
of the bladder seemed to be involved. Reed used the term "punctate ulcer,
"
while
Keene preferred "circumscribed panmural ulcerative cystitis" to describe the
thickening of the entire bladder wall associated with minute ulcerations of the
mucosa (145,90). It was known as "submucous ulcer" at the Mayo Clinic because it
was felt that the process involved primarily the submucosa (13). "Linear ulcer (67),"
"panmural fibrosis (25)," "submucous cystitis (34)," "panmural cystitis (9),"
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"submucous fibrosis (54)," "cystitis lymphopathia (143)," "cystitis infiltrans
circumscripta (136)," and "bladder fissure (68)" have all been used. Until 1949
new synonyms were being coined (143). Peterson encouraged the acceptance of
the term "interstitial cystitis" although it was first used by Skene to describe a
bacterial cystitis (136,161).
Incidence 4
Kinder and Smith (98) in 1958 reported an incidence for interstitial cystitis
of 0.15% for all urological admissions to St. Peter's Hospital in London over a ten
year period. Bowers and Lattimer (9) reported a 0.07% incidence in the same
population in this country. In first visit urology patients Von Garrelts (56) reported
a 0.24% to 0.29% incidence, while Peterson and Hager (136) reported a 0.47%
rate. Hand (65) reported the highest incidence rate in the literature for this same
group at 4.79%, but this has not been the common experience. Peterson (136)
reported a 1 .9% incidence in adult females with urologic problems, and Bowers and
Lattimer (9) reported a 2.1% incidence in all patients with cystitis.
In the pediatric population (1-12 yrs.), Geist and Antolak (57) reported a
4.8% incidence in their urological patients, while Chenoweth (20) reported a 1 .1%
rate in this group. Other papers report a surprisingly high incidence rate of inter
stitial cystitis in children. McDonald (116) reported a 12.1% incidence in children
with bladder dysfunction and Geist (57) reported an incidence of 14.3% in children
with voiding difficulty and sterile urine. These high incidences can be explained
by pre-selection as only those children with bladder dysfunction and sterile urine
were included.
Interstitial cystitis is not a common disease occurring in about 1-3/1,000
urologic hospital admissions which comprise 10% of all hospital admissions.
The disease most frequently affects middle aged females (20,57,116,61),
but has been observed in men (13,63,164), children (116,20,57), and the
elderly (61). The average age in a combined series was forty-seven (68,75,166,
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70,186,132,93,180). The female to male ratio has been reported to be 5.6:1.0
in a collected series of 1365 cases previously reported in the literature (9). This
ratio is not a true representative figure since cases in men are more frequently
reported than in women. The ratio of 11:1 reported by a single investigator, with
the largest series of over 400 patients, is probably more accurate (65).
The geographic distribution of this disease has not been studied, but
Somerset (168) states that interstitial cystitis is more common in the United States
than in Australia or Britain, and Shipton (157) states that it is rare in Europe.
Many attempts have been made to correlate interstitial cystitis with other
disorders because of its unknown etiology. Rheumatoid arthritis (132,158),
thyroiditis (158), chronic granulomatous disease (94), polyarteritis (132), idiopathic
muscle fibrosis (187), vaginitis, purpura, colitis, hypertension, sprue, cholecystitis,
pelvic inflammatory disease (9), endometriosis (181), lupus erythematosus (60),
tonsillitis (78), oral infection (122), and urethritis (79) have all been reported in
association with interstitial cystitis, but none has occurred with sufficient freauency
to suggest any causal relationship.
Presently there appear to be only two associated disorders: allergy and
carcinoma of the bladder arising from the site of a Hunner ulcer. The incidence of
a previous history of allergic disorders in patients with interstitial cystitis is greater
than expected in the normal population as reported by Hand (65), Higgins (70),
and Oravisto (132) with respective incidences of 14.7%, 19%, and 13%. Carcinoma
of the bladder arising from a Hunner's ulcer was first reported by Hagner in 1937 (62).
Previous to this Hunner had only one similar experience (81). Later Rusche and
Hager (151) reported twc cases, one with carcinoma occurring six months after
diagnosis of interstitial cystitis, and the other three years after diagnosis. Vose
and Dixey (176) reported two cases, one with carcinoma at the initial diagnosis
of interstitial cystitis, and the other three years after diagnosis. Bumpus and
Barrington (62) also reported one case each. Of the total nine cases, the diagnosis
of interstitial cystitis was made by cystoscopy with initial biopsies obtained only in
three cases. Kinder (93) in 1958 reported the misdiagnosis of interstitial cystitis for
carcinoma of the bladder in one case out of forty-two. And Badenoch (2) reported
two patients with carcinoma of the bladder who were referred to him for management
of their interstitial cystitis. Smith and Badenoch (167) reported three cases of
carcinoma of the bladder originally diagnosed as interstitial cystitis, and Cristol
(26) reported two similar cases. In review, except for the two cases of carcinoma
occurring three years after the initial diagnosis, all other cases can be attributed
to an error in diagnosis. Whether the actual two cases of carcinoma did arise from
the Hunner's ulcer and were causally related can not be ascertained. The available
data does noi allow for a comparison between the incidence of carcinoma of the
bladder in patients with interstitial cystitis and the incidence of carcinoma of the
bladder in the general population.
Clinical Presentation 7
The onset of interstitial cystitis is usually insidious, but may follow an
episode of acute cystitis (113,155). The most common symptom is "clocklike"
frequency and nocturia occurring as often as every fifteen minutes during the day
and hourly at night (55,93). Often this is associated with urgency. There is
usually a persistent, knife-like suprapubic pain which is Increased with bladder
distention, aggravated by sitting, movement, and menstruation, and alleviated by
bladder emptying (155,2,136). The patient may often place her finger over the
exact spot of the lesion (155). Rarely the pain is located in the right or left
quadrant and may simulate appendicitis. In females, the pain may radiate to the
rectum, vagina, thigh, hip, or buttocks. In males, the pain radiates to the penis
and increases with micturition (63). Dyspareunia, perineal and back pain, and
urinary retention are less common; intermittent hematuria, most often encountered
when the urine is self contained too long, dysuria, and burning on urination
occasionally occur (155). The systemic manifestations are rare and include weight
loss, weakness, lassitude, and anorexia (38). A combined series illustrates the
incidence of the various symptoms in decreasing order of frequency (65,166,38,100,
69): frequency 92%, nocturia 78%, dysuria 62%, suprapubic bladder pain 33%,
urgency 21%, intermittent hematuria 20%, burning 19%, back pain 11%,
incontinence 6%, and retention 2%.
The physical examination usually reveals only suprapubic tenderness and
tenderness over the base of the bladder on pelvic examination (2).
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The urine is usually clear, but microscopic examination reveals a few red
and white cells per high power field in approximately 90% of patients (38,70, 100,
162,146,3). The culture of the urine is usually sterile, but 50% of cases will have
positive cultures from a complicating episode of bacterial Infection during the
course of the disease (75,132,38,165). Urography reveals a normal genito-urinary
tract in most cases, unless there is a decrease in bladder capacity or complicating
hydroureter due to vesico-ureteral reflux or secondary obstruction from fibrosis. The
bladder emptying is normal (2) and cystometric studies are not helpful (149).
The differential diagnosis of interstitial cystitis must include: chronic
infective cystitis, tuberculosis, carcinoma of the bladder (especially in males),
radiation cystitis, bilharzia, pyogenic simple ulcers, syphilis, amebic cystitis,
bladder neck obstruction, fibrotic contracted bladder secondary to gonorrheal
infection, granular urethritis, lymphogranuloma venereum, and the psychosomatic
cystitis syndrome (2,41,24,65,93,133,161).
Pathology 9
There are numerous descriptions of the pathology of interstitial cystitis in
the literature (25,47,58,65,68,69,75,78,90,95,113,130,136,159,166,168,184,
187). The disease has been divided into three stages based on the cystoscopic,
macroscopic, and microscopic appearances of the lesion (43,65,120). Stage I
requires the presence of an ulceration, stage II is characterized by ulceration and
fibrosis, and stage III represents a markedly contracted fibrotic bladder.
Stage I
The cystoscopic feature shows that the ulcers or fissures are usually discrete
in the early stage and every centimeter of the bladder must be inspected (78). At
the site of a visible lesion the mucosa is pale (78,120) and is surrounded by a salmon
pink area of congestion interspersed with dilated capillaries in an irregular pattern.
When these areas are touched with an instrument or overdistended they character
istically bleed and readily manifest the typical appearance of the stellate ulcer
(75,78). The suprapubic pain which the patient experiences may be reproduced (68).
Overdistention of the bladder also produces numerous fissures with sharp edges
approximately 0.5 mm by 2.0 mm at the sites of increased vascularity which ooze
droplets of blood (75,78,90,68,120). These early lesions may be overlooked with
inadequate filling and led Young to recommend double distention of the bladder
(68,187). The fissure with bleeding is one of the characteristic findings in inter
stitial cystitis. The areas of mucosal pallor may be caused from previous ulceration
and scarring (154,68). Except for the area(s) of involvement, the mucosa appears
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normal . The apex of the bladder is most often involved, while the ureteral orifices
and trigone are usually spared. In a combined series of sixty-six cases the ulcers
were distributed in the following manner: apex 35%, right wall 16.5%, posterior
wall 16.5%, anterior wall 12%, left wall 11%, and trigone 9% (78,98,166,136,
13,122). Hand reported a 38% incidence of trigonal ulcers, a finding not
subsequently substantiated (65,18,83,168). Typically only one area is involved,
although 30% of cases have multiple ulcerations. The bladder capacity is normal
or only slightly reduced at this stage (65,78).
Descriptions of the gross pathology of case studies of interstitial cystitis
are limited since the disease is uncommon, and specimens are obtainable only at
autopsy or operation; there has been only one case report at necropsy (154) and
operative intervention is presently rare. The best descriptions are contained in early
publications when excision of the ulcer was the therapy of choice (58,75,90,98).
However, stage I lesions are not described.
The microscopic appearance of the bladder in interstitial cystitis shows a
chronic inflammatory process involving all layers of the bladder. The appearance
is very similar to chronic cystitis except for the additional fibrosis of the submucosa
(70). The histologic examination reveals that the entire bladder is involved
regardless of the position of the ulcer as demonstrated by multiple random bladder
biopsies in contrast to the macroscopic and cystoscopic findings of discrete
lesions (132).
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The mucosa in the involved area shows an atrophied and flattened
epithelium (68), with occasional thickening secondary to squamous metaplasia,
hornification, or goblet cell proliferation (78,184). The epithelium may be
thinned or cuboidal in areas of healed ulcers or where dense subepithelial deposits
raise the mucosa (68,70). At the edge of an active ulcer, the epithelium ends
abruptly with a precipitous edge, or there may be a single layer of cuboidal cells
attempting to bridge the ulcer gap (78). At the base of the ulcers there are red
blood cells or granulation tissue rich in capillaries with a preponderance of connective
tissue infiltrated by leukocytes and round cells, depending on the age of the
lesion (78,90). The basement membrane which is locally thickened is discontinuous
at the edge of the ulcer (78).
The submucosa is markedly thickened due to edema, cellular infiltration,
and fibrosis. The degree of edema may be disproportional to the amount of
inflammation as compared to that seen in simple ulceration of the bladder (166).
The cellular infiltrate is predominantly lymphocytic. Plasma cells, monocytes,
granulocytes, histiocytes, and mast cells may also be present (78,166). There may
be a follicular arrangement of lymphocytes and plasma cells with a scattered
infiltration of eosinophils in some cases (184). Connective tissue is increased and
related to the duration of the lesion (166). The lymph spaces are distended with
lymphocytes and granulocytes and the arteriolar walls may show thickening. Rarely
a perivascular infiltrate of leukocytes is present without arteriolar necrosis (65).
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The veins and capillaries are dilated with a modest accumulation of leukocytes.
Although these changes are diffuse, there is a tendency to focal prominence
especially around nerve trunks (166).
The muscularis is usually edematous throughout with lymphocytes and
plasma cells interspersed between muscle fibers, focal ly prominent at nerve
trunks (166). Mast cells, as demonstrated by Leder stain, are found scattered
throughout (166,160). The amount of fibrosis is proportional to the duration and
stage of the lesion and to the degree of inflammation. Early edema and
inflammation is generally replaced by fibrosis, and the late stage resembles
"linitis plastica of the non-neoplastic type (26,159,137)."
The peritoneum and paravesical tissues may be thickened with round cell
infiltrate or fibrosis (78,65,166), especially in the area of a large ulcer (58).
The adjacent perivesical fat may contain a round cell infiltrate (52). Bohm and
Franksson have reported round cell infiltration of sacral nerve roots with myelin
sheath degeneration, but this has not been confirmed (52,53,121).
Stage II
The cystoscopic appearance of this stage shows more areas of involvement,
larger ulcerations and longer fissures up to 7.0 mm (65,68,90). Fibrous tissue is
more prolific with pale raised bands stretching across the bladder wall. The bladder
capacity is markedly reduced to within 150 cc (65).
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Macroscopically, the bladder appears to be involved only in the areas of
ulceration. Here the entire bladder wall and the peritoneum is thickened. The
inflammatory process may extend to involve the paravesical tissues and adhesions
between the bladder and paravesical tissues have been noted (90,68). There is
contracture of the bladder with cicatrization.
The microscopic appearance is as in stage I with the additional characteristic
of an increase in fibrous tissue.
Stage III
Stage III represents "the end-stage bladder." The markedly reduced bladder
capacity of less than 150 cc. may make the cystoscopic examination difficult. The
amount of scar tissue is significantly increased over the earlier stages. The raised
ridges or bands of fibrous tissue criss cross from one side of the bladder to the other
(65,68,120) and form a stellate pattern (47,155). There is little or no edema and
the organ takes on the character of a "leather bag" with no distensibility and much
rigidity (155).
Macroscopically the bladder is small and the entire bladder wall is
thickened and fibrotic (90). The paravesical involvement may be substantial with
occasional obstruction of the ureters. Hydroureter may be due to obstruction, but
more often is due to reflux.
The microscopic feature of this stage is an increase in fibrosis and decrease
in edema.
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The pathogenesis of interstitial cystitis is of unknown etiology. It is a
chronic inflammatory process affecting the entire bladder wall without evidence of
a preceding acute or subacute process. It may be progressive and followed by
healing with cicatrization, undergo spontaneous remission, or arrest.
Etiology 15
The etiology of interstitial cystitis remains obscure. The theories that have
been proposed have little conclusive evidence to substantiate them. The principal
theories of etiology can be classified as infectious, vascular, lymphatic, neuro
genic, and immunologic.
Hunner in 1915 first postulated an infectious origin suggesting that a distant
suppurative focus with hematogenous spread of organisms incited a chronic infection
of the bladder wall (76,80). This was based on a previous work (77) in which he
claimed to have demonstrated a causal relationship, albeit invalid, between
tonsillitis and granular urethritis, and a finding that all of his patients with interstitial
cystitis had chronic urethritis. Bumpus insisted that as the bladder wall and not the
mucosa was mainly affected, the infection could not be transmitted by the urine, but
must be from a hematogenous spread (13). Rosenow was unable to detect any
localization in the bladder wall when organisms isolated from infected tonsils were
injected intravenously in rabbits and dogs (150), but LeFur (122) was able to
produce ulceration in the bladder- though not typical of interstitial cystitis, by
injecting non-specific organisms intravenously into rabbits and simultaneously injuring
the bladder wall. Bumpus (122) supported this concept by demonstrating submucosal
and mucosal hemorrhage in the bladders of rabbits injected with alpha streptococci
from periapical tooth infections in patients with interstitial cystitis. Similar lesions
however were found in the gallbladder, stomach, and kidneys. There has been no
other work which has supported the idea of an etiology due to a focus of infection.
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Interstitial cystitis has also been thought to occur from bladder wall infection
secondary to local spread of pelvic infection via lymphatics or following pelvic
surgery. Winsbury-White in 1933 injected India ink into the cervix of guinea pigs
and demonstrated ink particles in the bladder lymphatics and produced inflammatory
changes in the bladder following the injection of Mycobacteria tuberculosis into the
cervix of guinea pigs (186). Others have attributed the cystitis to lymphogranuloma
venereum (24,112) and Neisseria gonorrhea (41).
The evidence for an infective etiology is inconclusive. Many patients have
no focus of infection, and neither the removal of such foci, nor the use of anti
biotics have altered the course of the disease (91,52). Keene (91) and Kretchmer
(98) were unable to detect any pelvic infections in their series of thirty-four patients
with Interstitial cystitis. McCrea in 1962 was unable to reproduce the lesion with
group C streptococci injected directly into the bladder wall even with lymphatic
obstruction of the bladder (114). Smith was unable to culture any organisms from the
bladder wall macerated in culture medium (165). Recently Hanash and Pool cultured
the urine and bladder wall biopsies of thirty patients with interstitial cystitis for
viruses, bacteria, and fungi, all of which were sterile (64). This study has apparently
ended a controversy.
Keene suggested that the lesion of interstitial cystitis was secondary to a
paracystitis (90). Herbst in 1937 induced a paracystitis in female dogs by implanting
an infected bone spicule in a pouch created between the posterior bladder wall and
the uterus (68). All dogs had a decreased bladder capacity and mucosal hemorrhages
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were produced after prolonged bladder distention; however, the cystoscopic lesions
were not typical of interstitial cystitis and histologic examination showed only
chronic inflammatory changes in the area of the adhesions. A severe paracystitis is
uncommon in patients with the disease and occurs only in severe cases.
The theory of lymphatic obstruction in the bladder wall was proposed by
Powell in 1945, who was impressed by the similarity of the microscopic appearance
of interstitial cystitis and chronic lymphedema (142). He postulated that obstruction
of lymphatic flow: by infection as a result of pelvic inflammatory disease,
cervicitis, urethritis or proctitis; by mass obstruction by fibroids; or by surgical
interruption of lymphatics caused edema of the bladder wall. The edema was felt
to reduce blood flow, lower tissue oxygenation, and cause nerve irritability which
induced frequency of urination further impairing lymphatic flow. The edema would
ultimately result in fibrous proliferation. He obstructed lymphatic flow from the
bladder in dogs by intralymphatic injection of thorotrast which produced edema and
fibrosis, but there was no cellular infiltrate. It is of interest that enterocystoplasty
increased lymphatic flow via neocol lateralization, but does not ameliorate the
course of the disease (114).
Vascular insufficiency of the bladder has been suggested as a possible cause
of the disease by Engel on the basis that a few cases were found to have a decrease
in capillary vascularity in the fundus (43). Herbst ligated the posterior vessels to the
bladder in two dogs, but failed to produce the cystoscopic and histologic changes of
interstitial cystitis (68). Vascular narrowing or obstruction has not been observed in
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interstitial cystitis and enterocystoplasty, which increases the blood supply to the
bladder, does not prevent progression of the disease (114).
Hand in 1949 suggested a neurologic mechanism because of the prominence
of focal inflammation around nerve bundles which has been described elsewhere (65,
165). Bohm and Franksson (53) reported endoneural and perineural fibrosis with
myelin sheath degeneration and round cell infiltration in rhizotomy specimens of the
sacral nerves from patients with severe interstitial cystitis, but there were no adequate
controls and this finding has not been confirmed (121). Bladder capacity increases in
patients with interstitial cystitis following sacral neurectomy, evidence which has
been used to suggest a neurogenic component (126,135,185). Sacral neurectomy
however has a similar effect on the normal bladder. A lesion of the bladder consisting
of edema, round cell infiltration of the lamina propria and submucous fibrosis without
gross ulceration of the bladder wall has been produced in monkeys by application of
aluminum gel or lycopodium spores to the sacral nerve roots (121). These observations
have not been followed up.
More recently immunologic mechanisms have been invoked as a cause of
interstitial cystitis. Fister drew attention to the similarity of the lesions in interstitial
cystitis and lupus erythematosus and suggested a common etiology (47). Both diseases
are uncommon, usually occur in females, exhibit a chronic course, and have the
histopathologic characteristics of edema, round cell infiltration and fibrosis. Lupus
is now considered to be an auto-immune disease. Shipton also regarded interstitial
cystitis as a manifestation of a collagen disease and cited four cases associated with
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lupus erythematosus and scleroderma (157). Attempts have been made to detect
antibodies to bladder tissue in patients with chronic interstitial cystitis using fluorescent
antibody techniques. Silk (158) in 1970 claimed to have demonstrated anti-bladder
antibodies in the serum of nine of twenty patients with interstitial cystitis employing
an indirect Coons method and that these antibodies could not be detected in normal
patients, in those with chronic bacterial cystitis, or in patients with known anti
thyroid and anti-gastric antibodies. He incubated the patient's serum with normal
human bladder tissue and then incubated the bladder tissue with fluoroscein labeled
rabbit anti-human globulin antibody. This indirect Coons method is not always
reliable since non-specific reactions may occur. Silk did not demonstrate tissue
specificity since no other tissues were incubated with the serum as controls. The
specificity of a reaction should be determined by absorption of the antibody with non-
bladder antigens prior to incubation with the target cells.
Gordon et al. (60) reported the presence of IgA, IgM, and IgG in the muscle
or submucosa in the bladders of five of eight patients with interstitial cystitis. They
used the direct Coons method incubating fluorescein labeled rabbit anti-human IgA,
IgG, and IgM with sections of bladder from patients with interstitial cystitis. Three
of four patients with other bladder diseases however exhibited the presence of IgG and
IgM in the submucosa. No normal bladders were studied. They also found that five
of five patients with interstitial cystitis had anti-bladder antibodies in their sera as
shown by the indirect Coons method when their own bladders were used as the target
antigen. Both controls with other bladder diseases also exhibited this phenomenon.
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The pooled sera of five normal patients did not exhibit any evidence for the
presence of antibody when tested against the same bladder tissue. Again the
specificity of the reaction was not determined as other tissues were not used as
controls. Furthermore, in only two patients was the indirect Coons method positive
when the direct Coons was negative. In the other three patients the direct Coons
was initially positive, thus the indirect Coons was necessarily positive. He also
demonstrated lymphocytotoxic antibody in one patient and anti -nuclear factor in
two others, one of which also exhibited the LE phenomenon. He postulated an
antigen in the bladder was released or altered and induced an immune response in
the susceptible host which would initiate and perpetuate an inflammatory process in
the bladder, a conclusion for which there seems to be insufficient evidence.
Jokinen in 1970 (84) was unable to confirm Silk's findings of the presence of
anti-bladder antibodies in the serum of patients with interstitial cystitis. He used a
similar method; namely, incubation of the patient's serum with normal bladder tissue
prior to incubation with fluorescein labeled rabbit anti -human gamma globulin anti
body; however, he absorbed the test sera with lyophilized rat kidney, liver, and
homogenates of human uterine muscle to remove non-specific antibodies. This method
could conceivably have also removed the specific bladder antibodies which might
cross react with the antigens used for absorption. He subsequently was unable to
detect any specific immunoglobulin in the bladder basement membrane of patients with
interstitial cystitis using the direct Coons method (85), however, the fluorescein
labeled anti-human gamma globulin was absorbed with acetonized rat liver particles
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prior to testing which may explain why he was unable to confirm Gordon's findings.
It is of interest that patients with discoid lupus erythematosus were found to have
immunoglobulins present in the bladder basement membrane. Oravisto et al.
demontrated the presence of anti-nuclear antibodies in titers of greater than 1:10
in 28 of 33 patients with interstitial cystitis in the absence of a positive LE
phenomenon (132). They later reported an 85% incidence of anti-nuclear antibodies
in patients with interstitial cystitis compared with a 6% incidence in a control group
matched for sex and age (84). Antibodies to smooth muscle, mitochondria, thyroid
tissue, and cell nuclei were found in 94% of cases, but these were also present to
the same degree in the control group.
The response to steroid therapy, which has been suggested as indicating auto
immune disease (118) has been variable and inconclusive in patients with interstitial
cystitis (2,32,182). This may suggest that the bladder changes may not be due to
an immune process.
Treatment 22
The treatment of patients with interstitial cystitis is unsatisfactory in many
cases as the etiology remains obscure. However, many modes of therapy have
been used with varying degrees of success in producing relief of symptoms. Some
times remissions may be induced and occasionally the process is arrested though
probably this is due to the self limitation of the disease.
Almost all the empirical treatments developed have been abandoned, and
only a few are currently employed. Therapy can be divided into surgical and non
surgical and following is a tabulation of the methods that have been used.
Surgical Therapy
Local Excision
1) Extraperitoneal segmental excision of the ulcer (75, Hunner, 1914).
2) Simple cystotomy (58, Geraghty, 1917).
3) Transperitoneal resection of the ulcer (145, Reed, 1919).
4) Wide excision of the ulcer (66, Herbst, 1920).
5) Subtotal cystectomy (48, Folsom etal., 1940).
6) lleocystotomy (46, Ferris, 1955).
7) Sigmoidocystoplasty (56, von Garrelts, 1966).
8) Caecocystoplasty (56, von Garrelts, 1966).
Open Fulguration
1) Open gauze curettage of the ulcer (145, Reed, 1919).
2) Fulguration of the ulcer through the open bladder (100, Furniss, (1926).
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Transurethral resection and fulguration
1) Cystoscopic division of the fibrous bands in the bladder wall (155,
Seaman, 1950).
2) Transurethral resection of the urethra and removal of Skene's ducts
with cauterization (146, Riba, 1958).
3) Application of silver nitrate to the ulceration (75, Hunner, 1914).
4) Electrocauterization of the ulcer area (75, Hunner- 1919).
5) Application of the silver stick to the ulcer (75, Hunner, 1914).
6) Diathermy fulguration of the ulcer (101, Kreutzmann, 1922).
7) Shortwave diathermy fulguration (4, Barnes, 1947).
Neurectomy
1) Resection of the presacral nerve (144, Quinby, 1931).
2) Resection of the presacral nerve and division of the paravertebral
chains and sacral rami communicantes (104, Learmonth, 1931).
3) Presacral neurectomy and sacral ganglionectomy (135, Pearl, 1938).
4) Anterolateral chordotomy (129, Nesbit, 1947).
5) Differential sacral neurectomy (127, Moulder and Meirowsky, 1956).
Urinary Diversion
1) Bilateral ureterosigmoidostomy in two separate stages (23, Cousellor,
1937).
2) Bilateral simultaneous ureterosigmoidostomy (1 10, Lower and
Schlumberger, 1939).
3) Ileal loop conduit applied to interstitial cystitis (11, Bricker, 1950;
2, Badenoch, 1971).
Non-surgical Therapy 24
Bladder Distention and Urethral Dilatation
1) Distention of the bladder by the method of Young (75, Hunner, 1914).
2) Dilatation of urethral strictures and ureteral strictures (79, Hunner,
1920).
3) Overdistention of the bladder (99, Frontz, 1922), popularized by
Bumpus (15, Bumpus, 1930).
4) Self distention of the bladder by delaying micturition, (144, Quinby,
1931), popularized by Ormond (133, Ormond, 1935).
5) Gradual prolonged bladder distention by means of a balloon catheter
(89, Kearns, 1932).
6) Mechanical periodic bladder distention and irrigation by means of
tidal irrigation (107, Longacre, 1936).
7) Distention of the bladder by means of a condom (8, Bohne and Fetz,
1954).
8) Distention of the bladder with Chlorpactin WCS-90, monoxy-








llation of bichloride of mercury (75, Hunner, 1914).
Motion of gomenol oil (75, Hunner, 1914).
llation of boric acid (75, Hunner, 1914).
llation of Thompson fluid (75, Hunner, 1914).
llation of silver iodide (90, Keene, 1920).
llation of argyrol (170, Stevens, 1923).
7) Intravesical instillation of acriflavine and mercurochrome (91, Braasch,
1925).
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8) Intravesical instillation of silver nitrate in increasing concentrations
(33, Dodson, 1926).
9) Application of pure phenol (156, Sears, 1935).
10) Intravesical instillation of triphenylmethane (30, Davis, 1941).
11) Intravesical instillation of amniotin oil (39, Eikner, 1942).
12) Intravesical instillation of histamine and hyaluronidase (143, Powell,
1949).
13) Intravesical instillation of cajaput oil (3, Baker and Callahan, 1959).
14) Intravesical instillation of iodophor (181, Warres , 1962).
15) Intravesical instillation of dimethyl sulfoxide, DMSO (172, Stewart
etal., 1968).
Bladder Injection
1) Transurethral injection of absolute alcohol into the submucosa in
and around the ulcer (1, Alexander, 1936).
2) Transurethral infiltration of adrenalin and procaine into the ulcer
(149, Rose, 1951).
3) Transurethral injection of hydrocortone hyaluronidase into the sub
mucosa and muscularis around the ulcer (153, Schulte and Reynolds,
1956).
4) Local hydrocortisone for Hunner's ulcer (183, Johnstone, 1956).
Oral and Parenteral Medication
1) Removal of allergic foods and adrenalin by intramuscular injection
(37, Duke, 1922).
2) Intravenous administration of mercurochrome (40, Eisenstadt, 1931).
3) Intravenous gold sodium thiosulfate and intramuscular bismuth (47,
Fister, 1937).
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4) Parenteral administration of emetine chloride (102, Henline, 1941).
5) Intramuscular streptomycin in interstitial cystitis with superimposed
urinary tract infection (152, Satrerthwaite and White, 1948).
6) Oral administration of thiamine chloride (143, Powell, 1949).
7) Supplementary estrogen therapy in post-menopausal females with
interstitial cystitis (143, Powell, 1949).
8) Oral administration of potassium iodide (65, Hand, 1949).
9) Parenteral ACTH therapy (182, Weaver and Tyler, 1950).
10) Oral administration of alpha tocopherol (175, Van Duzen and Mustain,
1951).
11) Oral administration of cortisone (73, Hoyt, 1952).
12) Oral administration of banthine (148, Riskind, 1952).
13) Oral administration of an antihistamine, pyribenzamine (160, Simmons
and Bunce, 1958).
14) Oral administration of potassium p-amino benzoate (113, McCrea, 1960).
15) Intravenous administration of heparin (183, Weaver, 1963).
16) Oral administration of prednisolone (61, Guerrier et a I., 1965).
17) Oral administration of oxyphenbutazone (61, Guerrier et al ., 1965).
Miscellaneous
1) External ultraviolet irradiation (69, Higgins, 1930).
2) Immobilization of the bladder by an indwelling catheter (92, Keyes,
1922).
3) Deep X-ray therapy (102, Kreutzmann, 1941).
4) Novocaine infiltration of the erector nerves by the parasacral route
(28, Darget, 1944).
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5) Dilatation of the bladder with bimanual bladder massage (143,
Powell, 1949).
6) Transurethral application of ultraviolet irradiation to the ulcer
(19, Caulk and Ewerhardt, 1952).
It has been difficult to evaluate these various modes of therapy since the
disease is uncommon; series are small; few studies are controlled in respect to the
experimental modality, and the stage of the disease treated. The commonly
accepted procedures are discussed below.
Hydraulic overdistention of the bladder, first described by Frontz (99)
and popularized by Bumpus (15) has been the primary treatment for all grade lesions,
and is commonly used in conjunction with other therapy. Distention has usually
to be performed under anesthesia to be effective. Because rupture of the bladder is
more common with caudal anesthesia due to nerve blockage and maximal muscle
relaxation, general anesthesia is recommended (40). Daily gradual bladder
distention or one maximal distention is employed. Franksson reported no signifi
cant difference in bladder capacity or in relief of symptoms between these two
protocols (52). Bumpus (15) originally reported "gratifying results" in one hundred
patients. Franksson (52) in a study of thirty-three patients reported a one-month
remission in twelve cases, two to six-month remissions in fourteen cases, and greater
than six-month remissions in seven cases.
Fulguration of the ulcer endoscopically with electric current appears to be
a useful adjunct in the therapy of interstitial cystitis. The application should be
mild to prevent fibrosis and perforation (180,40). The effect is temporary relief of
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pain probably due to destruction of C nerve fibres although no data is available
to confirm this generally accepted notion.
Instillation of various chemicals which produce a hyperemia of the bladder
wall is often used. Silver nitrate in 1:5000 to 1:100 dilution in increasing
concentrations is used as an adjunct to bladder distention, although it may be used
alone (33). In one hundred and eighty-seven cases treated by distention and silver
nitrate instillation, 14% greatly improved, 79% improved, and 7% showed no
improvement in respect to frequency, nocturia, and pain (16). The average duration
of remission was forty-two days. This is only minimally better than distention alone.
Chlorpactin WCS-90, monoxychlorosene, used as a 0.2% solution, in weekly
instillations for five weeks is beneficial in decreasing pain and frequency (131,128).
O'Conor (131) reported a 100% therapeutic response initially, and Murnaghan (128)
in a two-year follow-up study reported in seventeen patients: 35% greatly improved,
41% improved, and 24% unchanged with respect to pain and frequency. In both
studies, 58% of patients required repeated courses of therapy. This is significant
since increased fibrosis may be a long term effect of monoxychlorosene (180).
Dimethyl sulfoxide, DMSO, is an anti-inflammatory, antiseptic, and analgesic
agent, which, when used as an intravesical irrigant has been shown to give sympto
matic relief in 75% of cases (171). Further experimental trials have been discontinued
by the Federal Drug Administration pending further evaluation of its toxic effects.
The antihistamines, heparin and pyribenzamine, may afford minimal relief.
Pyribenzamine 50 mgm three times a day orally gave some relief to four of six patients,
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however other therapy was given simultaneously and the study was not conducted
as a double-blind trial (159). Heparin, 20,000 units intravenously over twenty-
four hours combined with an initial intravesical irrigation with heparin was reported
to relieve symptoms within forty-eight hours, but no follow-up is given (183).
Systemic administration of cortisone 100 mgm daily and prednisone 10-20 mgm
daily for three weeks has been used with variable results. Hoyt (73) reported no
significant effect in four patients, while Guerrier (61) reported relief of pain in
nine of eleven patients and decreased frequency in five. Dees (32) noted a decrease
in pain and frequency with increased bladder capacity in three of four patients,
but all patients relapsed after medication was discontinued. Only Badenoch (2)
in 1971 reported significant improvement with steroid therapy. In his series nineteen
of twenty-five patients improved with continued daily steroids; of note, all patients
were overdistended at the time steroids were begun. Frankson (52) reported a dramatic
initial response, but all patients relapsed after the steroids were discontinued.
Presently the data suggests that steroid therapy may be beneficial, but must be
continued indefinitely to maintain a remission.
Banthine, a parasympatholytic agent, has been reported to decrease frequency
and nocturia, without relieving pain in a trial of three patients (143).
Surgical intervention in the treatment of interstitial cystitis is indicated
when there is intractable pain, when fibrosis has extended to produce a small
contracted bladder necessitating frequent micturition which is unresponsive to
conservative therapy, or when ureteral stenosis or reflux causes hydronephrosis.
The surgical treatment of choice for intractable bladder pain is sacral
rhizotomy (52,53), if patients are properly selected. Patients with pain in a
sacral nerve root distribution respond more favorably than those whose pain is not
well localized (53). This can be determined preoperative! y by examination and
by observing a decrease in pain following infiltration of the sacral nerve roots
with local anesthetic agent (52,53). Other authors report an increase in bladder
capacity with a decrease in frequency following this procedure (135,126,185).
The surgical treatment of the chronic contracted bladder is some form of
cystoplasty or a urinary diversion. Caecocystoplasty, colocystoplasty, or ileo-
cystoplasty have been used (53,23,110). A subtotal cystectomy with removal of
all the bladder except the trigone should be performed, and the bowel is anastomosed
to the remaining trigonal tissue. This must be done to avoid severe cicatrization
at the anastomotic site. Caecocystoplasty is the procedure of choice because of
caecal isoperistalsis (53). Frequency is diminished, but pain frequently reoccurs
within six months secondary to trigonal spasm (53). Ureterosigmoidostomy has
limited usefulness because of the high incidence of ascending infection, hyper-
chloremic acidosis, osteoporosis, and decreased renal function (147). The ileal
conduit has been applied to the treatment of interstitial cystitis. This procedure is
more advantageous than ureterosigmoidostomy because there is a low incidence of
ascending infection, only a 10% incidence of hyperchloremic acidosis, and in the
hands of the usual surgeon will give the most consistent success. Occasionally the
surgeon may be obligated to perform a ureterosigmoidostomy if the abdominal stoma
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will not be tolerated. Badenoch (2) has collected a series comparing these various
procedures.
Procedure No. Improved No change Worse Died
Ureterocolic anastomosis 6 4 0 0 2
Cystoplasty 9 5 0 4 0
Ileal conduit 3 3 0 0 0
In patients with intractable and disabling symptoms, urinary diversion is a last resort.
Despite all of the methods above some patients are not relieved symptomatica I ly




There is only one report of an attempt to induce interstitial cystitis in
animals by immunologic methods. Silk in 1970 was unable to produce any lesions in
rats or rabbits following a single intramuscular injection of homologous bladder antigen
(5 mgm) in complete Freund's adjuvant (158). This amount of crude antigen is
small compared to doses of 200-400 mg which have been successfully used to produce
lesions in other organs (31,87,29). Multiple injections of antigen will sometimes
produce a lesion when single injections of antigen are unsuccessful (31). Heterologous
antigens, moreover, are occasionally more effective than homologous antigen in
producing a tissue specific auto-immune lesion (28,31,87).
An attempt was made to reproduce the lesions of interstitial cystitis in rats
by hyperimmunization with heterologous bladder antigen obtained from rabbits in
varying doses and after single and multiple injections accompanied by simultaneous
mechanical and bacteriological injury to the bladder.
Materials and Methods 2
Animals:
Ten to eleven week old male and female Sprague-Dawley rats weighing
between 100 and 150 grams were used. They were segregated by sex and kept five
to a cage and fed water and Purina rat pellets ad libitum.
Rabbit Bladder Antigen :
New Zealand albino male rabbits, approximately weighing two kilograms,
were sacrificed. Bladders were aseptically removed, debrided of fat and major
blood vessels, rinsed with sterile normal saline, dried with sterile gauze, weighed,
frozen in dry ice, and ground with mortar and pestle to a granular powder. The
ground material was further homogenized in a Dual I ground glass tissue homogenizer
in sterile normal saline for ten minutes to yield a final concentration of 600 mgm/ml.
Dilutions of 200 mgm/ml and 60 mgm/ml were made with sterile normal saline and
rehomogenized for two minutes. Homogenates were stored at -20C in sterile Falcon
tubes. On the day of injection, the homogenates were thawed and rehomogenized
for two minutes.
Rabbit Skeletal Muscle Antigen and Rabbit Stomach Antigen:
The left rectus femoris muscle and stomachs were also removed aseptically
from the same rabbits and treated in the same manner. Final concentrations of the
homogenates was 600 mgm/ml.
Preparation of Complete Freund's Adjuvant:
170 cc of Bayol F/Marcol 52 and 30 cc of Arlacel A/mannide mononucleate
3
(Atlas Chemical Co.) and 1 .2 grams of heat-killed, freeze-dried, ground Myco
bacteria strains C,D,T,P, and N (Ministry of Agriculture; Surrey, England;
courtesy Dr. Byron Waksman) were mixed in a sterile bottle by agitation. This
complete Freund's adjuvant was stored at -20C. The final concentration contained
6 mgm/ml of Mycobacteria.
Preparation of Antigen-Adjuvant Mixtures:
Fresh mixtures were prepared on each day of injection. Tissue homogenates
and a sterile normal saline control were added to complete Freund's adjuvant in a
1 :1 ratio (by volume), emulsified with a syringe, and then mixed with a Thomas
teflon homogenizer for five minutes. Mixtures were tested for emulsification by
the absence of dispersal when droplets of the mixture were placed on a water surface.
Final concentrations were: Rabbit Bladder Antigen: 300 mgm/ml, 100 mgm/ml, and
30 mgm/ml; Rabbit Skeletal Muscle Antigen: 300 mgm/ml; and Rabbit Stomach
Antigen: 300 mgm/ml.
Experimental Design:
All rats were anesthetized with diethyl ether prior to injection according to
fhe following protocols.
Protocol "A":
Sixty rats were divided into seven sex equal groups, and were injected with
1 .0 ml of an antigen adjuvant mixture, 0.5 cc distributed among 3 footpads
excluding the left hind side, and 0.1 cc in each of five subcutaneous sites in the









On the tenth, fourteenth, twenty-first, and twenty-eighth day after the injections,










Sixty rats were divided into seven groups identical to those in Protocol "A1
and given the same initial injection. At two-week intervals all animals were
re-injected with 0.5 cc of the same antigen-adjuvant mixture in the right flank,
in five subcutaneous sites (0.1 cc per site), for a maximum of four re-injections.
On the twenty-eighth, forty-second, fifty-sixth, and seventieth day after the
original injection, one-fourth of each original group was sacrificed.
Protocol "C":
Four rats, on the day following the fourth re-injection (as in Protocol "B")
were operated upon to induce bladder injury.
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Rat Antigen Dose
1 Bladder 300 mgm/ml
2 Bladder 100 mgm/ml
3 Bladder 30 mgm/ml
4 Saline Control
After induction of anesthesia with Nembutal 30 mgm/ml intraperitoneally, the
suprapubic area was shaved and cleansed with benzalkonium and 95% ethyl alcohol.
A vertical midline suprapubic incision was made to expose the bladder. The dome of
the bladder was clamped with a small hemostat for three minutes and the abdomen
was closed. The animals were sacrificed on the fourteenth postoperative day.
Protocol "D":
A
group of four rats identical to those in Protocol "C" were operated upon
fourteen days after the fourth re-injection. They were prepared and anesthetized
in the same manner. A 3 mm round glass bead was inserted into the bladder through
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a small cystotomy, the bladder was closed with 6.0 catgut. A 0.1 ml of 10 cells/ml
of E. coli strain ECY (courtesy L. Freedman) was then injected into the bladder with
a *27g needle 5 mm from the incision site. The rats were sacrificed on the fourteenth
postoperative day.
Method of Sacrifice:
Animals were sacrificed with ether. The viscera were examined macro
scopically after the thorax and abdomen were exposed. Sections of the left rectus
femoris muscle, stomach, urinary bladder, heart, lung, kidney, liver, spleen,
6
and left testis or left ovary were removed and fixed in 10% neutral formalin.




In the gross examination there was no difference in the appearance between
the control and the experimental bladders or any other organ. Residual of pleural
fibrosis were found in occasional animals from each group. In microscopic section,
there was no difference with respect to the bladder histology when examined for
edema, cellular infiltration, or fibrosis.
Protocol "B"
The results in this study were similar to that found in "A".
Protocol "C"
In the gross examination, there was minimal thickening of the bladder wall
in the area of injury. In microscopic section, all bladders appeared to have a
minimal increase in fibrosis in this injured area. There was neither cellular infiltrate
nor edema. There was no difference between the experimental animals and the controls.
Protocol "D"
In the gross examination, all animals showed thickening of the bladder wall
at the suture site with minimal peritoneal adhesion. The microscopic examination
findings were similar to those in Protocol "C," without evidence of cystitis or infection.
Discussion
Interstitial cystitis has many characteristics of an auto-immune disease:
the chronic clinical course; the association with collagen diseases; the age and
sex distribution; the histopathology; an apparent response in some patients to steroid
and antihistamine therapy; and the presence of antinuclear factor and anti-bladder
antibodies in some patients (157,2,159,183,60,158). In addition, Waksman states
that, "any disease of unknown etiology in which infection, tumor, and deficiency
state have been ruled out, may be suspicious of having an immunologic basis (178)."
There are two broad categories of auto-immune disease: tissue specific and
non-tissue specific (178). The latter are characterized by the following: antibodies
that react widely with different tissues of the same and other species, e.g., anti-
nuclear factor; antigens that are accessible to the lymphatic circulation and available
to immunologically competent cells, e.g., nucleoprotein; an increased incidence of
antibodies that react to various tissues, e.g., antithyroid antibodies; a familial
pattern; antibodies that react with antigens to which normal individuals are tolerant,
e.g., anti-DNA; and a lesion which is difficult to produce in experimental animals
(178). Two examples of non-specific auto-immune disease are systemic lupus
erytematosus and rheumatoid arthritis. These diseases are thought to be caused by
an immunologic abnormality that allows the formation of auto-antibodies and auto-
sensitized lymphocytes to react against unaltered, non-foreign antigen. In summary,
there is a "central" failure to recognize "own" antigens (178), to which tolerance
is normally developed.
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The tissue specific diseases have different characteristics: auto-antibodies
that react(s) with (a) component(s) from a single organ from many species; the
relevant antigens may be separated from lymphatic contact, e.g., lens capsular
protein; tolerance to these antigens usually is not developed in the host; and
experimentally the lesions can be produced in animals by the injection of the tissue
specific antigen incorporated in complete Freund's adjuvant (177,178). Hashimoto's
thyroiditis, post-rabies vaccination encephalomyelitis, and idiopathic Addison's
disease are thought to represent this category of auto-immune disease. The lesion is
thought to occur from an humoral and/or cellular response to the non-tolerant antigen,
and is believed to be initiated in the following ways: unaltered endogenous antigen,
previously "hidden" from the lymphatic system gains entry to the latter inducing an
immunologic response; antigen to which the host is tolerant becomes altered, e.g.
by infarction, initiating an immunologic response which cross reacts with the original
antigen; exogenous antigen induces an immunologic response which cross reacts with
endogenous antigen, e.g., rheumatic fever; or a "forbidden clone" produces anti
bodies and/or lymphocytes that react with a tolerant or nontolerant antigen as in
paroxysmal nocturnal hemoglobinuria.
Interstitial cystitis does not appear, however, to belong to either group
exclusively. The disease does not represent a non-tissue specific disease totally.
Although 85% of patients have been reported to have antinuclear factor in greater
than 1:10 titer (84,132), patients do not have an increased incidence of other
auto-antibodies when compared to matched controls (84). Although three cases have
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been reported with the LE phenomenon (60,157), this has not been a consistent
finding (84). These findings are probably only coincidental, rather than providing
evidence that interstitial cystitis is a variant of lupus.
Interstitial cystitis does not represent tissue specific disease totally either.
In only nine of Silk's twenty patients were anti-bladder antibodies demonstrated (158),
a finding not confirmed by Jokinen (84). Furthermore, Gordon was able to
demonstrate such antibodies in patients with a variety of bladder disorders (60).
Gordon reported one patient whose lymphocytes underwent blastogenesis as measured
by radioactive thymidine uptake when exposed to bladder antigen, but this patient
also demonstrated the LE phenomenon, and it is not clear to which disease this
phenomenon should be attributed to since no other patients were tested. Patients
with tissue specific auto-immune diseases are reported to have a higher incidence of
auto-antibodies to other organs, but this is not characteristic of interstitial cystitis
(84). McGuire and Lytton in a clinical report found histopathologic changes of
round cell infiltration and fibrosis in the submucosa of colonic tissue which had been
used for a colocystopiasty as treatment in a case of chronic interstitial cystitis.
This lesion was undistinguishable from the bladder lesion in interstitial cystitis. Finally,
Silk was unable to produce this lesion in rats or rabbits experimentally by the injection
of homologous antigen (158). The present investigation also failed to produce any
bladder lesions following hyperimmunization with heterologous antigen in rats. There
are several possible explanations which could account for this failure:
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1) Animals were not sensitized because:
a) bladder protein is a poor antigen (this, however, is
probably not a factor since when guinea pigs were
skin tested with bladder protein after hyperimmunization
with bladder antigen in a complete Freund's adjuvant,
delayed hypersensitivity occurred.)
b) antigen doses were inappropriate
c) the preparation of the protein destroyed its antigenic
properties
d) the animals were or became tolerant to the antigen
2) Animals were sensitized, but
a) rabbit bladder antigen does not cross react with rat
bladder
b) anti-bladder antibody "blocked" cytotoxic lymphocytes
3) Rats are not subject to auto-immune disease of the bladder
Only further investigation will clarify these points.
Chronic interstitial cystitis, if indeed is an auto-immune disease, would be
considered to have some characteristics of both types of auto-immune disease as
suggested by Jokinen (84). Presently the data suggests that immunologic mechanisms
are not the cause of interstitial cystitis, but that these patients may exhibit immuno
chemical abnormalities.
Further investigation must be pursued both experimentally and clinically if
the etiology is to be more clearly defined. Testing for the presence of the LE
phenomenon, antinuclear factor, complement level, circulating anti-bladder anti
bodies, lymphocyte toxicity to bladder cells, and lymphocyte blastogenesis upon
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exposure to bladder protein could be evaluated in patients with clearly defined
interstitial cystitis and might be of help in determining whether in fact the
condition should be considered a true auto-immune disease.
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